Shunli Tang

748 total citations
24 papers, 496 citations indexed

About

Shunli Tang is a scholar working on Immunology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Shunli Tang has authored 24 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Shunli Tang's work include Autoimmune and Inflammatory Disorders Research (7 papers), Eosinophilic Disorders and Syndromes (5 papers) and Immune Cell Function and Interaction (5 papers). Shunli Tang is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (7 papers), Eosinophilic Disorders and Syndromes (5 papers) and Immune Cell Function and Interaction (5 papers). Shunli Tang collaborates with scholars based in China and United States. Shunli Tang's co-authors include Jianjun Qiao, Hong Fang, Yuwei Ding, Shuni Ying, Taoming Liu, Sheng Li, Yali Li, Sheng Li, Dingxian Zhu and Shan Zhang and has published in prestigious journals such as Frontiers in Immunology, Journal of the American Academy of Dermatology and Carcinogenesis.

In The Last Decade

Shunli Tang

23 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunli Tang China 11 215 147 118 110 98 24 496
Nilgün Atakan Türkiye 13 194 0.9× 191 1.3× 87 0.7× 60 0.5× 110 1.1× 47 531
Mark S. Fradin United States 8 306 1.4× 178 1.2× 162 1.4× 72 0.7× 131 1.3× 10 578
Diletta Bonciani Italy 11 80 0.4× 166 1.1× 104 0.9× 28 0.3× 204 2.1× 22 450
İlkin Zindancı Türkiye 11 102 0.5× 143 1.0× 144 1.2× 55 0.5× 149 1.5× 55 418
A. Howland Hartley United States 4 239 1.1× 143 1.0× 70 0.6× 51 0.5× 55 0.6× 8 378
Igor Snast Israel 11 158 0.7× 271 1.8× 102 0.9× 44 0.4× 148 1.5× 41 555
Maryam Sadr Iran 13 254 1.2× 21 0.1× 84 0.7× 191 1.7× 164 1.7× 67 580
Carol R. Drucker United States 9 62 0.3× 135 0.9× 121 1.0× 70 0.6× 84 0.9× 13 477
Bart W. Boom Netherlands 14 171 0.8× 200 1.4× 85 0.7× 96 0.9× 118 1.2× 23 478
Vimal H. Prajapati Canada 13 249 1.2× 588 4.0× 89 0.8× 53 0.5× 179 1.8× 87 861

Countries citing papers authored by Shunli Tang

Since Specialization
Citations

This map shows the geographic impact of Shunli Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunli Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunli Tang more than expected).

Fields of papers citing papers by Shunli Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunli Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunli Tang. The network helps show where Shunli Tang may publish in the future.

Co-authorship network of co-authors of Shunli Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shunli Tang. A scholar is included among the top collaborators of Shunli Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunli Tang. Shunli Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Dingxian, Shuni Ying, Shunli Tang, et al.. (2024). Clinical features of macrophage activation syndrome in adult dermatomyositis: A single‐center retrospective case‐control study. Immunity Inflammation and Disease. 12(1). e1141–e1141. 3 indexed citations
2.
3.
Li, Sheng, Shunli Tang, Xiaoxuan Cai, et al.. (2023). Risk factors of cardiovascular involvement in patients with Behcet's disease. Journal of Translational Autoimmunity. 6. 100195–100195. 4 indexed citations
4.
5.
Tang, Shunli, Sheng Li, Shuni Ying, et al.. (2022). Underlying Systemic Diseases in Interstitial Granulomatous Dermatitis and Palisaded Neutrophilic Granulomatous Dermatitis: A Systematic Review. Dermatology. 239(2). 287–298. 4 indexed citations
6.
Tang, Shunli, et al.. (2022). Evaluation of Serum Proinflammatory Cytokine IL‐17A and Tight Junction Protein Claudin‐1 in Psoriasis. Contrast Media & Molecular Imaging. 2022(1). 6092808–6092808. 1 indexed citations
7.
Tang, Shunli, Sheng Li, Yuwei Ding, et al.. (2022). Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome. Journal of Autoimmunity. 133. 102929–102929. 16 indexed citations
8.
Ding, Yuwei, Shunli Tang, Sheng Li, et al.. (2021). Risk of macrophage activation syndrome in patients with adult-onset Still's disease with skin involvement: A retrospective cohort study. Journal of the American Academy of Dermatology. 85(6). 1503–1509. 7 indexed citations
9.
Zhu, Dingxian, et al.. (2020). Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis. Lara D. Veeken. 60(8). 3896–3903. 18 indexed citations
10.
Ying, Shuni, Sheng Li, Shunli Tang, et al.. (2020). <p>Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum</p>. Journal of Inflammation Research. Volume 13. 471–476. 2 indexed citations
11.
Liu, Taoming, Sheng Li, Shuni Ying, et al.. (2020). The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside. Frontiers in Immunology. 11. 594735–594735. 223 indexed citations
12.
Zheng, Siting, Sheng Li, Shunli Tang, et al.. (2020). Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy. Frontiers in Medicine. 7. 20–20. 20 indexed citations
13.
Tang, Shunli, et al.. (2020). Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification. Frontiers in Medicine. 7. 587773–587773. 29 indexed citations
14.
Li, Sheng, Siting Zheng, Shunli Tang, et al.. (2019). Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease. Clinical Reviews in Allergy & Immunology. 58(1). 71–81. 33 indexed citations
15.
Tang, Shunli, Siting Zheng, Sheng Li, et al.. (2019). Association between serum ferritin and the severity of drug eruptions. Journal of Clinical Laboratory Analysis. 34(2). e23043–e23043. 5 indexed citations
16.
Qiao, Jianjun, Sheng Li, Shunli Tang, et al.. (2019). Adult-Onset Still Disease Presenting With Dermatomyositis-Like Persistent Pruritic Lesions. American Journal of Dermatopathology. 41(11). 851–854. 4 indexed citations
17.
Qiao, Jianjun, Sha Zhou, Shunli Tang, et al.. (2018). Histopathological diagnosis of persistent pruritic eruptions associated with adult‐onset Still's disease. Histopathology. 74(5). 759–765. 17 indexed citations
18.
Chen, Yi‐Ming, Jingjing Qiu, Shunli Tang, et al.. (2017). Research on the inhibitory effect of metformin on human oral squamous cell carcinoma SCC-4 and CAL-27 cells and the relevant molecular mechanism. Biomedical Research-tokyo. 28(14). 6350–6354. 1 indexed citations
19.
Zhang, Dandan, Zhenli Li, Xiaohong Xu, et al.. (2017). Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome. Carcinogenesis. 38(11). 1057–1062. 5 indexed citations
20.
Yu, Dan, Zhenli Li, Meifu Gan, et al.. (2015). Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients. Tumor Biology. 36(11). 8531–8535. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nilgün Atakan Breakdown of academic impact, for papers by Mark S. Fradin Breakdown of academic impact, for papers by Diletta Bonciani Breakdown of academic impact, for papers by İlkin Zindancı Breakdown of academic impact, for papers by A. Howland Hartley Breakdown of academic impact, for papers by Igor Snast Breakdown of academic impact, for papers by Maryam Sadr Breakdown of academic impact, for papers by Carol R. Drucker Breakdown of academic impact, for papers by Bart W. Boom Breakdown of academic impact, for papers by Vimal H. Prajapati
Rankless by CCL
2026